39
Views
6
CrossRef citations to date
0
Altmetric
Article

Pharmacological inhibition of DNA repair enzymes differentially modulates telomerase activity and apoptosis in two human leukaemia cell lines

, , , , , & show all
Pages 593-605 | Received 03 May 2003, Accepted 20 May 2004, Published online: 03 Jul 2009
 

Abstract

Purpose: To investigate the effect of wortmannin and 3‐aminobenzamide (3‐AB) on telomerase activity and apoptosis in two human leukaemia cells.

Materials and methods: MOLT‐4 (p53‐wild type) and KG1a (p53‐null) cells were irradiated with γ‐rays (3 Gy at 1.57 Gy min−1) and the effects of wortmannin and 3‐AB were evaluated. Telomerase activity was measured by polymerase chain reaction and the expression of human telomerase reverse transcriptase, human telomerase RNA and telomerase‐associated protein 1 was assessed by reverse transcriptase‐polymerase chain reaction. Apoptosis was evaluated by fluorescence microscopy and flow cytometry.

Results: A radiation‐induced up‐regulation of telomerase activity was observed from 4 h post‐irradiation in both cell lines. This up‐regulation was abrogated by wortmannin and 3‐AB. Telomerase activity was maximal 24 h post‐irradiation, coinciding with an accumulation of human telomerase reverse transcriptase mRNA. Apoptosis and G2/M arrest were evident from 4 h post‐irradiation in MOLT‐4 cells. KG1a cells exhibited a G2/M block at 24 h post‐irradiation and apoptosis increased between 24 and 48 h post‐irradiation. 3‐AB abolished G2/M blockage and enhanced radiation‐induced apoptosis in both cell lines, while wortmannin increased apoptosis only in MOLT‐4 cells.

Conclusions: 3‐AB inhibits the radiation‐associated telomerase activity increase and enhances apoptosis in MOLT‐4 and KG1a cells. Wortmannin, which also inhibits the radiation‐associated telomerase activity increase in both cell lines, does not modify radiation‐induced apoptosis in KG1a cells. DNA repair enzymes might be selective targets for enhancing radiosensitivity in certain tumour cells.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.